1. Home
  2. EPM vs LCTX Comparison

EPM vs LCTX Comparison

Compare EPM & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$3.63

Market Cap

133.7M

Sector

Energy

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

255.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
LCTX
Founded
2003
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.7M
255.4M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
EPM
LCTX
Price
$3.63
$1.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$4.83
$6.25
AVG Volume (30 Days)
537.4K
965.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
10.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,229,621.00
$14,556,000.00
Revenue This Year
N/A
$109.40
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$3.19
$1.00
52 Week High
$5.10
$2.09

Technical Indicators

Market Signals
Indicator
EPM
LCTX
Relative Strength Index (RSI) 50.77 39.23
Support Level $3.48 N/A
Resistance Level $3.79 $1.18
Average True Range (ATR) 0.15 0.05
MACD 0.00 -0.00
Stochastic Oscillator 44.16 6.25

Price Performance

Historical Comparison
EPM
LCTX

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: